1-7 of 7
Ernst Kubista
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Low p27 Expression Predicts Early Relapse and Death in Postmenopausal Hormone Receptor–Positive Breast Cancer Patients Receiving Adjuvant Tamoxifen Therapy

Martin Filipits, Margaretha Rudas, Harald Heinzl, Raimund Jakesz, Ernst Kubista, Sigurd Lax, Walter Schippinger, Otto Dietze, Richard Greil, Wolfgang Stiglbauer, Werner Kwasny, Alexander Nader, Michael Stierer, Michael F.X. Gnant, for the Austrian Breast and Colorectal Cancer Study Group
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (18): 5888–5894.
https://doi.org/10.1158/1078-0432.CCR-09-0728
Published: 14 September 2009
View article titled, Low p27 Expression Predicts Early Relapse and Death in Postmenopausal Hormone Receptor–Positive Breast Cancer Patients Receiving Adjuvant Tamoxifen Therapy
Open the PDF for Low p27 Expression Predicts Early Relapse and Death in Postmenopausal Hormone Receptor–Positive Breast Cancer Patients Receiving Adjuvant Tamoxifen Therapy in another window
Journal Articles

Effect of Tibolone on Breast Cancer Cell Proliferation in Postmenopausal ER+ Patients: Results from STEM Trial

Ernst Kubista, Juan V.M. Planellas Gomez, Mitch Dowsett, Jean-Michel Foidart, Kamil Pohlodek, Rudolphe Serreyn, Michail Nechushkin, Alexey G. Manikhas, Victor F. Semiglazov, Cornelius C.M. Hageluken, Christian F. Singer
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (14): 4185–4190.
https://doi.org/10.1158/1078-0432.CCR-06-2700
Published: 18 July 2007
View article titled, Effect of Tibolone on Breast Cancer Cell Proliferation in Postmenopausal ER+ Patients: Results from STEM Trial
Open the PDF for Effect of Tibolone on Breast Cancer Cell Proliferation in Postmenopausal ER+ Patients: Results from STEM Trial in another window
Journal Articles

Insulin-Like Growth Factor (IGF)-I and IGF-II Serum Concentrations in Patients with Benign and Malignant Breast Lesions: Free IGF-II Is Correlated with Breast Cancer Size

Christian F. Singer, Maurice Mogg, Wolfgang Koestler, Margit Pacher, Erika Marton, Ernst Kubista, Martin Schreiber
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (12): 4003–4009.
https://doi.org/10.1158/1078-0432.CCR-03-0093
Published: 24 June 2004
View article titled, Insulin-Like Growth Factor (IGF)-I and IGF-II Serum Concentrations in Patients with Benign and Malignant Breast Lesions: <subtitle>Free IGF-II Is Correlated with Breast Cancer Size</subtitle>
Open the PDF for Insulin-Like Growth Factor (IGF)-I and IGF-II Serum Concentrations in Patients with Benign and Malignant Breast Lesions: <subtitle>Free IGF-II Is Correlated with Breast Cancer Size</subtitle> in another window
Journal Articles

Interleukin 1 System and Sex Steroid Receptor Expression in Human Breast Cancer: Interleukin 1α Protein Secretion Is Correlated with Malignant Phenotype

Christian F. Singer, Nicole Kronsteiner, Gernot Hudelist, Erika Marton, Ingrid Walter, Marion Kubista, Klaus Czerwenka, Martin Schreiber, Michael Seifert, Ernst Kubista
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (13): 4877–4883.
Published: 27 October 2003
View article titled, Interleukin 1 System and Sex Steroid Receptor Expression in Human Breast Cancer: <subtitle>Interleukin 1α Protein Secretion Is Correlated with Malignant Phenotype</subtitle>
Open the PDF for Interleukin 1 System and Sex Steroid Receptor Expression in Human Breast Cancer: <subtitle>Interleukin 1α Protein Secretion Is Correlated with Malignant Phenotype</subtitle> in another window
Journal Articles

Overexpression of Hypoxia-inducible Factor 1α Is Associated with an Unfavorable Prognosis in Lymph Node-positive Breast Cancer

Monika Schindl, Sebastian F. Schoppmann, Hellmut Samonigg, Hubert Hausmaninger, Werner Kwasny, Michael Gnant, Raimund Jakesz, Ernst Kubista, Peter Birner, Georg Oberhuber, the Austrian Breast Colorectal Cancer Study Group
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (6): 1831–1837.
Published: 01 June 2002
View article titled, Overexpression of Hypoxia-inducible Factor 1α Is Associated with an Unfavorable Prognosis in Lymph Node-positive Breast Cancer
Open the PDF for Overexpression of Hypoxia-inducible Factor 1α Is Associated with an Unfavorable Prognosis in Lymph Node-positive Breast Cancer in another window
Journal Articles

Evaluation of the United States Food and Drug Administration-approved Scoring and Test System of HER-2 Protein Expression in Breast Cancer

Peter Birner, Georg Oberhuber, Josephine Stani, Cornelia Reithofer, Hellmut Samonigg, Hubert Hausmaninger, Ernst Kubista, Werner Kwasny, Daniela Kandioler-Eckersberger, Michael Gnant, Raimund Jakesz, the Austrian Breast & Colorectal Cancer Study Group
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (6): 1669–1675.
Published: 01 June 2001
View article titled, Evaluation of the United States Food and Drug Administration-approved Scoring and Test System of HER-2 Protein Expression in Breast Cancer
Open the PDF for Evaluation of the United States Food and Drug Administration-approved Scoring and Test System of HER-2 Protein Expression in Breast Cancer in another window
Journal Articles

Messenger RNA Determination of Estrogen Receptor, Progesterone Receptor, pS2, and Plasminogen Activator Inhibitor-1 by Competitive Reverse Transcription-Polymerase Chain Reaction in Human Breast Cancer

Dan Tong, Christian Schneeberger, Klaus Czerwenka, Rita K. Schmutzler, Paul Speiser, Elisabeth Kucera, Nicole Concin, Ernst Kubista, Sepp Leodolter, Robert Zeillinger
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (6): 1497–1502.
Published: 01 June 1999
View article titled, Messenger RNA Determination of Estrogen Receptor, Progesterone Receptor, pS2, and Plasminogen Activator Inhibitor-1 by Competitive Reverse Transcription-Polymerase Chain Reaction in Human Breast Cancer
Open the PDF for Messenger RNA Determination of Estrogen Receptor, Progesterone Receptor, pS2, and Plasminogen Activator Inhibitor-1 by Competitive Reverse Transcription-Polymerase Chain Reaction in Human Breast Cancer in another window